Quick answer
This page lists every compound in the CoreVionRX catalog with what it is, the net amount per vial and the kind of published research that has examined it (cell, animal or human studies). Everything is supplied as lyophilized powder with a lot-specific COA, for laboratory research use only.
Use this reference to compare compounds by structure and by the evidence that exists for them. It does not describe how to use any compound. For composition, lab prep and storage details, follow the links to each product page and research guide.
Connective Tissue and Cell Migration Research
| Compound | What it is | Net per vial | Published research (study type) |
|---|---|---|---|
| BPC-157 | Synthetic 15-amino-acid peptide | 10mg | Mostly rodent and cell studies; very limited human data |
| TB-500 (Thymosin Beta-4) | Synthetic peptide related to thymosin beta-4, an actin-binding protein | 5mg | Cell and animal studies of cell migration and actin regulation |
| GHK-Cu | Copper(II) complex of the tripeptide Gly-His-Lys; blue powder | 100mg | Cell-culture and animal studies of collagen and gene expression |
Metabolic Pathway Research
| Compound | What it is | Net per vial | Published research (study type) |
|---|---|---|---|
| GLP-3RT | Investigational single peptide acting on GIP, GLP-1 and glucagon receptors (Eli Lilly, LY3437943) | 30mg | Phase 1–3 human trials published by Lilly; not FDA-approved |
| MOTS-c | 16-amino-acid peptide encoded in mitochondrial DNA | 40mg | Cell and mouse studies of the AMPK pathway |
| AOD9604 | Modified fragment of the C-terminal end of human growth hormone | 10mg | Animal studies and human clinical trials |
| NAD+ | Nicotinamide adenine dinucleotide, a coenzyme (not a peptide) | 500mg | Cell and animal studies of NAD+ metabolism |
Neuroscience Research
| Compound | What it is | Net per vial | Published research (study type) |
|---|---|---|---|
| Semax | Heptapeptide Met-Glu-His-Phe-Pro-Gly-Pro, built from an ACTH (4-7) fragment | 10mg | Mainly rodent neuroscience models |
| Selank | Heptapeptide analog of tuftsin | 5mg | Mainly rodent studies |
| DSIP | Delta sleep-inducing peptide, a nonapeptide | 10mg | Mainly animal studies of sleep regulation |
Melanocortin Receptor Research
| Compound | What it is | Net per vial | Published research (study type) |
|---|---|---|---|
| PT-141 (Bremelanotide) | Cyclic melanocortin receptor agonist (MC3R/MC4R) | 10mg | Receptor and clinical studies; an FDA-approved prescription drug (Vyleesi), supplied here as research material |
| Melanotan II | Cyclic analog of alpha-MSH; non-selective melanocortin receptor agonist | 10mg | Animal and small human studies; not approved by the FDA |
Telomere and Immune Research
| Compound | What it is | Net per vial | Published research (study type) |
|---|---|---|---|
| Epithalon | Synthetic tetrapeptide Ala-Glu-Asp-Gly | 10mg | Cell and animal studies of telomerase activity |
| Thymosin Alpha-1 | 28-amino-acid thymic peptide (thymalfasin) | 10mg | Cell, animal and human clinical studies; not FDA-approved |
Growth Hormone Axis Research
| Compound | What it is | Net per vial | Published research (study type) |
|---|---|---|---|
| CJC-1295 (no DAC) + Ipamorelin Blend | Modified GRF (1-29), a GHRH analog, plus ipamorelin | 10mg | Studies of each component; see the guide below |
| Ipamorelin | Pentapeptide; selective ghrelin receptor (GHS-R1a) agonist | 5mg | Animal and early human studies |
| Tesamorelin | 44-amino-acid GHRH analog | 10mg | Human clinical trials; an FDA-approved prescription drug (Egrifta), supplied here as research material |
Reproductive Endocrinology Research
| Compound | What it is | Net per vial | Published research (study type) |
|---|---|---|---|
| Kisspeptin-10 | 10-amino-acid fragment of kisspeptin; KISS1R agonist | 5mg | Animal and human physiology studies |
Research Blends
| Blend | Composition per vial | Total |
|---|---|---|
| GLOW | GHK-Cu 50mg + BPC-157 10mg + TB-500 10mg | 70mg |
| KLOW | GHK-Cu 50mg + BPC-157 10mg + TB-500 10mg + KPV 10mg | 80mg |
| Wolverine Stack | BPC-157 + TB-500 | 20mg |
GLOW and KLOW differ only by KPV: KLOW is GLOW plus 10mg of KPV. See the peptide blends guide for a side-by-side comparison.
How Similar Compounds Differ
BPC-157 vs TB-500
They are unrelated molecules. BPC-157 is a 15-amino-acid synthetic peptide, while TB-500 is related to thymosin beta-4, an actin-binding protein. Both appear in the GLOW blend at 10mg each. The BPC-157 vs TB-500 comparison goes into more detail.
CJC-1295 vs Ipamorelin vs the Blend
The two act at different receptors. CJC-1295 without DAC (modified GRF 1-29) is a GHRH analog that binds the GHRH receptor; ipamorelin binds the ghrelin receptor (GHS-R1a). The CJC-1295 (no DAC) + Ipamorelin blend holds both in one 10mg vial. The CJC-1295 + Ipamorelin research guide explains the DAC and no-DAC forms.
Tesamorelin vs Modified GRF (1-29)
Both are GHRH analogs. Tesamorelin covers all 44 amino acids of GHRH, while modified GRF (1-29) uses only the first 29, with amino acid substitutions.
Storage and Lab Prep
All CoreVionRX peptides ship as lyophilized powder. Lab prep steps and mg/mL concentration tables are in the research guides for KLOW, GLOW, GHK-Cu, Epitalon and CJC-1295 + Ipamorelin. Bacteriostatic Water 10mL is available as a lab supply, and the peptide reconstitution calculator is also on the site. See the Peptide Storage Guide for storage by compound type.
All information is for laboratory research purposes only. Not intended for human use.
